Police Dog Dies of Lymphoma

The police department in Parma, OH laid to rest one of their own Friday. K-9 Carlo, Parma’s last police dog, died of lymphoma.



The Belgian Malinois served Parma’s Police Department seven of its eight years. Handler Jeff Wells and police dogs from nearly 25 different departments held a funeral for the dog at a local pet cemetery. It’s doubtful he’ll be replaced.



“Right now, based on the manpower, the financial shortcomings and the problems we’re having with the levy, I just don’t see it happening any time soon, which is unfortunate,” Officer Wells said.



Carlo was trained in narcotics detection, criminal apprehension, building searches and crowd control. In his seven years on the force, he helped put countless criminals in jail and helped get millions of dollars in drugs off the streets.



Editor's note: lymphoma is not contagious - many animals come down with lymphoma and it has no relation to humans getting lymphoma.



Source: WKYC Cleveland

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap